Current status of allogeneic and autologous blood and marrow transplantation: Report from the IBMTR and ABMTR — North America

This publication has 21 references indexed in Scilit:

• Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
  New England Journal of Medicine, 1994
• Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups
  The Lancet, 1994
• Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
  New England Journal of Medicine, 1994
• Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
  The Lancet, 1993
• Increasing Utilization of Allogeneic Bone Marrow Transplantation
  Annals of Internal Medicine, 1992
• Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
  The Lancet, 1992
• Bone Marrow Transplantation: What Is the Question?
  Annals of Internal Medicine, 1990
• Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1987
• Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis
  New England Journal of Medicine, 1987
• Circulating autologous stem cells collected in very early remission from acute non‐lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy
  British Journal of Haematology, 1985